Skip to main content
. 2015 Apr 13;102(7):813–825. doi: 10.1002/bjs.9765

Fig. 4.

Fig. 4

No adverse effects following LSKL (leucine–serine–lysine–leucine) peptide administration. a Haematoxylin and eosin staining of lung, heart and kidney at 24 h after hepatectomy. b Biochemical examination of blood at 6 h. Values are mean(s.d.). AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; BUN; blood urea nitrogen